Similarly, GSTP1 Ile/Val and Val/Val mutant genotype expression was significantly higher in CML patients 20(15%) and 56(38%) compared to control groups 21(12%) and 6(4%) respectively. Here, GSTP1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.